ArcticZymes Technologies ASA (OSL:AZT)

Market Cap	1.50B
Revenue (ttm)	104.33M
Net Income (ttm)	2.80M
Shares Out	51.07M
EPS (ttm)	0.05
PE Ratio	535.68
Forward PE	100.10
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,842
Average Volume	33,869
Open	30.50
Previous Close	29.40
Day's Range	29.80 - 30.50
52-Week Range	12.34 - 31.40
Beta	0.48
RSI	59.03
Earnings Date	Nov 6, 2025

About OSL:AZT

ArcticZymes Technologies ASA, a life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, in vitro diagnostics, and biomanufacturing. The company offers shrimp alkaline phosphatase for cleanup prior to Sanger sequencing and next generation sequencing processes; cod UNG for use in viral and other molecular diagnostic assays for the removal of contaminating dU-DNA; salt active nucleases for the removal of nucleic acids during manufacturing of viral vectors, recombinant proteins, and other...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1990
• Employees: 54
• Stock Exchange: Oslo Børs
• Ticker Symbol: AZT

Financial Performance

In 2024, OSL:AZT's revenue was 108.11 million, a decrease of -9.65% compared to the previous year's 119.65 million. Earnings were 8.47 million, a decrease of -56.40%.